CClinicalTrials.gg
CompletedNCT03106103Updated Apr 10, 2017

Incidence of Symptomatic and Asymptomatic Bacteriuria After Urodynamic Study in Women

An observational study in Female Stress Incontinence, sponsored by Federal University of São Paulo. Completed. Open to female participants aged 18 Years to 82 Years. Per ClinicalTrials.gov, last updated 2017-04-10.

Sponsored by Federal University of São Paulo · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
217
Ages
18 Years to 82 Years
Sex
Female
01

Study summary

Urodynamic Study (UDS) represents a series of agreed-upon clinical tests and is used to evaluate the functional status of the lower urinary tract, providing a pathophysiological basis for urinary symptoms. Urodynamic Study involves catheterization of the lower urinary tract. The prevalence of urinary tract infection after UDS ranges from 1,5% to 30 %.

Studies of prophylactic antibiotics for UDSs have offered data of contradictory and limited predictive values. Some investigators concluded that prophylactic antibiotics were valuable and others have not.

The objective of this study is to evaluate the efficacy of antibiotic prophylaxis before UDS in women, using different antibiotic regimens.

Read the detailed description

This study is randomized, double blind study was carried out in the Department of Gynecology at Sao Paulo Federal University from January 2009 to December 2012.

The patients were randomized in four groups: Group A received 500mg of levofloxacin, group B received placebo, group C received 80mg trimethoprim and 400mg sulfamethoxazole (SMZ-TMP) and group D received 100mg of nitrofurantoin. The tablets were administered 30 minutes before de UDS.

All patients were instructed to collect midstream urine sample to the microbiology laboratory 14 days after the UDS. Significant bacteriuria was considered when >1.000.000 organisms/mL of a single species was isolated.

All data were entered into Statistical Package for Social Sciences (SPSS) 16.0 for statistical analysis and graphic representation. Likelihood -ratio test and Fisher's exact test were used to compare the prevalence of significant bacteriuria after UDS in the different groups and Student's t-test and ANOVA test were used to compare continuous variables. To compare the groups regarding the BMI variable and parity, the model analysis of variance (ANOVA) was used, or if necessary, the nonparametric Kruskal-Wallis test and to compare the groups in relation to menopause variable, we used the Chi-square test. A significance level of 0.05 was established for statistical analysis.

02

Conditions studied

  • Female Stress Incontinence

Keywords

  • urodynamics
  • cystitis
  • prophylactic antibiotics
  • bacteriuria
03

Who can participate

Ages eligible
18 Years to 82 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

women with urinary dysfunction

Eligibility criteria

  • Inclusion Criteria: Women with 20 to 85 years old, clinical diagnosis of urinary incontinence with indication for urodynamic study, absence of genital prolapse or prolapse peak effort that does not exceed the hymen, absence of urinary tract infection
  • Exclusion Criteria: Patients with diabetes mellitus, history of recurrence urinary tract infection, with genital prolapse that exceed de hymen, pregnant, kidney stone, allergy to antibiotics, use of urethral catheters delay
04

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
217 participants (actual)
Target follow-up
1 Year
Patient registry
Yes

Groups and cohorts

  • Women with urinary incontinence

    The patients were randomized in four groups: Group A received 500mg of levofloxacin, group B received placebo, group C received 80mg trimethoprim and 400mg sulfamethoxazole (SMZ-TMP) and group D received 100mg of nitrofurantoin.

05

What researchers measure

Primary outcomes

  1. Incidence of symptomatic and asymptomatic bacteriuria after urodynamic study in women with urinary incontinence

    Time frame: 24 months

06

Study locations

No study locations are listed for this record.

07

Registry details

Key details

Study ID
NCT03106103
Lead sponsor
Federal University of São Paulo
Responsible party
Elizabeth Yukie Hirakauva (doctor, Federal University of São Paulo) — Principal investigator
First posted
Apr 10, 2017
Start date
Feb 2009
Primary completion
Dec 2012
Completion
Dec 2014
Last update
Apr 10, 2017

Study contacts

Elizabeth Hirakauva, Doctor
principal investigator · Federal University of São Paulo

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion